525 SURGICAL MORBIDITY AND MORTALITY FROM THE NEORESII TRIAL: STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER

525 SURGICAL MORBIDITY AND MORTALITY FROM THE NEORESII TRIAL: STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER

Saved in:
Bibliographic Details
Published in:Diseases of the esophagus Vol. 33; no. Supplement_1
Main Authors: Nilsson, K, Klevebro, F, Rouvelas, I, Lindblad, M, Szabo, E, Halldestam, I, Smedh, U, Wallner, B, Johansson, J, Johnsen, G, Kjus Ahlin, E, Johannessen, H, Hjortland, G, Bartella, I, Schröder, W, Bruns, C, Nilsson, M
Format: Journal Article
Language:English
Published: 14-09-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1120-8694
1442-2050
DOI:10.1093/dote/doaa087.139